|
US2018015061A1
|
|
Antimicrobial-antibiofilm compositions and methods of use thereof
|
|
CA2953401A1
|
|
Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
|
|
US2014322351A1
|
|
Biofilm-removing antimicrobial compositions and uses thereof
|
|
AU2014225252A1
|
|
Antimicrobial-antibiofilm compositions and methods of use thereof
|
|
CA2903266A1
|
|
Antimicrobial-antibiofilm compositions and methods of use thereof
|
|
WO2014134701A1
|
|
Antimicrobial-antibiofilm compositions and methods of use thereof
|
|
CN104010653A
|
|
Compositions And Methods For Preventing And Treating Oral Diseases
|
|
WO2012159216A1
|
|
Bone tissue regenerating peptides
|
|
EP2389071A1
|
|
Biofilm-removing antimicrobial compositions and uses thereof
|
|
CA2720301A1
|
|
Dispersinb tm, 5-fluorouracil, deoxyribonuclease i and proteinase k-based antibiofilm compositions and uses thereof
|
|
EP2162004A1
|
|
Antimicrobial compositions and uses thereof
|
|
US2011008402A1
|
|
Souluble b-n-acetylglucoseaminidase based antibiofilm compositions and uses thereof
|
|
WO2007053945A1
|
|
Oral anti-microbial composition comprising competence-stimulating peptide
|
|
CN101212906A
|
|
Antimicrobial compositions for inhibiting growth and proliferation of a microbial biofilm on medical devices
|
|
NZ556114A
|
|
Peptides capable of inhibiting Streptococcus mutans genetic competence and biofilm formation
|
|
US2006067951A1
|
|
Signal peptides, nucleic acid molecules and methods for treatment of caries
|
|
WO2005018701A1
|
|
Synergistic antimicrobial compositions and methods of inhibiting biofilm formation
|
|
US2005233950A1
|
|
Synergistic antimicrobial compositions and methods for reducing biofilm formation
|
|
US2005049181A1
|
|
Synergistic antimicrobial compositions and methods of inhibiting biofilm formation
|
|
CA2450504A1
|
|
Csrc polynucleotides and uses thereof for biofilm modulation
|
